Sigma Investment Counselors Inc Bristol Myers Squibb CO Transaction History

Sigma Investment Counselors Inc

$2.05 Billion
Q3 2024

A detailed history of Sigma Investment Counselors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sigma Investment Counselors Inc holds 34,476 shares of BMY stock, worth $1.99 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

34,476

Previous 37,544 8.17%

Holding current value

$1.99 Million

Previous $1.56 Million 14.43%

% of portfolio

0.09%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$39.66 - $51.75 $121,676 - $158,769	-3,068 Reduced 8.17%	34,476 $1.78 Million
Q2 2024 Jul 25, 2024	SELL	$40.25 - $52.99 $1.28 Million - $1.68 Million	-31,702 Reduced 45.78%	37,544 $1.56 Million
Q1 2024 Apr 25, 2024	SELL	$47.98 - $54.4 $93,561 - $106,080	-1,950 Reduced 2.74%	69,246 $3.76 Million
Q4 2023 Jan 22, 2024	BUY	$48.48 - $57.85 $218,402 - $260,614	4,505 Added 6.76%	71,196 $3.65 Million
Q3 2023 Oct 23, 2023	SELL	$57.89 - $64.73 $123,016 - $137,551	-2,125 Reduced 3.09%	66,691 $3.87 Million
Q2 2023 Jul 21, 2023	SELL	$63.71 - $70.74 $20,323 - $22,566	-319 Reduced 0.46%	68,816 $4.4 Million
Q1 2023 Apr 28, 2023	BUY	$65.71 - $74.53 $7,556 - $8,570	115 Added 0.17%	69,135 $4.79 Million
Q4 2022 Jan 27, 2023	SELL	$68.48 - $81.09 $34,376 - $40,707	-502 Reduced 0.72%	69,020 $0
Q3 2022 Oct 24, 2022	SELL	$0.13 - $76.84 $117 - $69,232	-901 Reduced 1.28%	69,522 $4.94 Million
Q2 2022 Jul 15, 2022	BUY	$72.62 - $79.98 $29,846 - $32,871	411 Added 0.59%	70,423 $5.42 Million
Q1 2022 Apr 20, 2022	BUY	$61.48 - $73.72 $15,738 - $18,872	256 Added 0.37%	70,012 $5.11 Million
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $81,034 - $94,467	-1,511 Reduced 2.12%	69,756 $4.35 Million
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $36,034 - $42,209	609 Added 0.86%	71,267 $4.22 Million
Q2 2021 Aug 04, 2021	SELL	$61.91 - $67.42 $78,563 - $85,555	-1,269 Reduced 1.76%	70,658 $4.72 Million
Q1 2021 Apr 30, 2021	SELL	$59.34 - $66.74 $87,526 - $98,441	-1,475 Reduced 2.01%	71,927 $4.54 Million
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $2.02 Million - $2.29 Million	34,993 Added 91.11%	73,402 $4.55 Million
Q3 2020 Oct 20, 2020	SELL	$57.43 - $63.64 $2.19 Million - $2.42 Million	-38,084 Reduced 49.79%	38,409 $2.32 Million
Q2 2020 Jul 31, 2020	BUY	$54.82 - $64.09 $297,562 - $347,880	5,428 Added 7.64%	76,493 $4.5 Million
Q1 2020 Apr 22, 2020	BUY	$46.4 - $67.43 $7,331 - $10,653	158 Added 0.22%	71,065 $3.96 Million
Q4 2019 Jan 21, 2020	BUY	$49.21 - $64.19 $1.06 Million - $1.38 Million	21,467 Added 43.42%	70,907 $4.55 Million
Q3 2019 Oct 18, 2019	BUY	$42.77 - $50.71 $337,925 - $400,659	7,901 Added 19.02%	49,440 $2.51 Million
Q2 2019 Jul 23, 2019	SELL	$44.62 - $49.34 $262,856 - $290,661	-5,891 Reduced 12.42%	41,539 $1.88 Million
Q1 2019 Apr 26, 2019	SELL	$45.12 - $53.8 $8,392 - $10,006	-186 Reduced 0.39%	47,430 $2.26 Million
Q4 2018 Feb 01, 2019	SELL	$48.76 - $63.23 $260,670 - $338,027	-5,346 Reduced 10.09%	47,616 $2.48 Million
Q3 2018 Oct 23, 2018	BUY	$55.19 - $62.25 $34,493 - $38,906	625 Added 1.19%	52,962 $3.29 Million
Q2 2018 Jul 24, 2018	SELL	$50.53 - $62.98 $7,933 - $9,887	-157 Reduced 0.3%	52,337 $2.9 Million
Q1 2018 Apr 30, 2018	SELL	$59.92 - $68.98 $26,244 - $30,213	-438 Reduced 0.83%	52,494 $3.32 Million
Q4 2017 Feb 08, 2018	BUY	$59.94 - $65.35 $37,042 - $40,386	618 Added 1.18%	52,932 $3.24 Million
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $2.89 Million - $3.33 Million	52,314	52,314 $3.33 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Investment Counselors Inc with notifications on news.

Account

Sigma Investment Counselors Inc Bristol Myers Squibb CO Transaction History